EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2261
https://www.valueinhealthjournal.com/article/S1098-3015(24)02475-6/fulltext
Title :
EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02475-6&doi=10.1016/j.jval.2024.03.2261
First page :
Section Title :
Open access? :
No
Section Order :
10256